Dr. Kocoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-2632Fax+1 410-328-6896
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2003 - 2006- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1999 - 1999
Hacettepe University FOMClass of 1996
Certifications & Licensure
MD State Medical License 2014 - 2026
CT State Medical License 2010 - 2015
AR State Medical License 2006 - 2011
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer
Blood Advances. 2025-03-15 - Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.Doris K Hansen, Lauren C Peres, Danai Dima, Alicia Richards, Leyla Shune
Journal of Clinical Oncology. 2025-02-18 - 10 citationsSafety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.Surbhi Sidana, Krina K Patel, Lauren C Peres, Radhika Bansal, Mehmet H Kocoglu
Blood. 2025-01-02
Abstracts/Posters
- Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain BarrierMehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...Mehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
